Table 3.
SNP | VA score change | CRT change (μm) | ||||||
---|---|---|---|---|---|---|---|---|
Letters | ≥15 letters gain | N | Median | P* | ||||
N | Mean ± SD | P | n (%) | P | ||||
CFH rs800292 | ||||||||
TT | 11 | 17.6 ± 17.6 | 0.065 | 7 (63.6) | 0.041 | 11 | −120.0 | 0.620 |
TC | 56 | 10.0 ± 14.0 | 19 (33.9) | 53 | −47.0 | |||
CC | 73 | 7.3 ± 13.1 | 19 (26.0) | 65 | −71.0 | |||
ARMS2 rs10490924 | ||||||||
GG | 16 | 12.4 ± 10.9 | 0.005 | 6 (37.5) | 0.015 | 16 | −134.0 | 0.445 |
GT | 44 | 14.0 ± 13.5 | 21 (47.7) | 38 | −69.0 | |||
TT | 83 | 6.0 ± 13.9 | 19 (22.9) | 77 | −81.0 | |||
HTRA1 rs11200638 | ||||||||
GG | 16 | 12.4 ± 10.9 | 0.002 | 6 (37.5) | 0.027 | 16 | −134.0 | 0.473 |
GA | 43 | 14.5 ± 12.7 | 20 (46.5) | 37 | −71.0 | |||
AA | 85 | 5.9 ± 14.1 | 20 (23.5) | 79 | −81.0 |
CRT: central retinal thickness; SD: standard deviation; SNP: single-nucleotide polymorphism; VA: visual acuity.
*Nonparametric testing.